After overcoming a life-threatening superbug, Ben "Verse" Mount now faces a diagnosis of acute monoblastic leukemia and has ...

Mitochondria are vital to energy production in cells and so play a key role in fueling cancer growth. However, how ...

Druthers Brewing Company co-founder Brian “Hart” Martell has died. He passed away with his family by his side. on Dec. 27 at the age of 43 following a battle with leukemia. According to his obituary, ...

Shares of Curis jumped after the company released what it assessed as positive data from a study of its in-development treatment for leukemia. The stock was up 33%, to $4.07, in midday trading ...

The Boston Celtics do a lot of great work in their community, as does their star forward Jayson Tatum. And the St. Louis ...

Venetoclax is under clinical development by AbbVie and currently in Phase II for Relapsed Acute Myeloid Leukemia.

Veliparib ER is under clinical development by AbbVie and currently in Phase II for Relapsed Acute Myeloid Leukemia.

Colorado physicians helped research a new treatment protocol for the most common form of childhood cancer that has “instantly ...

Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.

University of Minnesota Duluth (UMD) men's hockey senior Will Francis shared on Thursday that his leukemia has relapsed.

Practice-changing studies in both frontline CLL and relapsed/refractory disease, presented at ASH 2024, are discussed by Dr Jennifer Woyach.